Intra-bone cord blood hematopoietic stem cell transplantation (University of Brescia)

N/A

Report date: 2024/09/29 20:00:07

Base Information

Drug NameIntra-bone cord blood hematopoietic stem cell transplantation (University of Brescia)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Brescia Università Degli Studi Di Brescia

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversità Degli Studi Di Brescia

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A